Crossref journal-article
Springer Science and Business Media LLC
Nature Medicine (297)
Bibliography

Yung, E., Sorin, M., Pal, A., Craig, E., Morozov, A., Delattre, O., Kappes, J., Ott, D., & Kalpana, G. V. (2001). Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1. Nature Medicine, 7(8), 920–926.

Authors 9
  1. Eric Yung (first)
  2. Masha Sorin (additional)
  3. Achintya Pal (additional)
  4. Errol Craig (additional)
  5. Alexei Morozov (additional)
  6. Olivier Delattre (additional)
  7. John Kappes (additional)
  8. David Ott (additional)
  9. Ganjam V. Kalpana (additional)
References 33 Referenced 107
  1. Pani, A. & Marongiu, M.E. Anti-HIV-1 integrase drugs: How far from the shelf? Curr. Pharm. Des. 6, 569–584 (2000). (10.2174/1381612003400759) / Curr. Pharm. Des. by A Pani (2000)
  2. Pommier, Y. & Neamati, N. Inhibitors of human immunodeficiency virus integrase. Adv. Virus Res. 52, 427–458 (1999). (10.1016/S0065-3527(08)60310-3) / Adv. Virus Res. by Y Pommier (1999)
  3. Mathe, C. & Nair, V. Potential inhibitors of HIV integrase. Nucleosides Nucleotides 18, 681–682 (1999). (10.1080/15257779908041539) / Nucleosides Nucleotides by C Mathe (1999)
  4. Asante-Appiah, E. & Skalka, A.M. Molecular mechanisms of retroviral DNA integration. Antiviral Res. 36, 139–156 (1997). (10.1016/S0166-3542(97)00046-6) / Antiviral Res. by E Asante-Appiah (1997)
  5. Brown, P.O. Integration of retroviral DNA. Curr. Topics Microbiol. Immunol. 157, 19–48 (1990). / Curr. Topics Microbiol. Immunol. by PO Brown (1990)
  6. Desrosiers, R.C. Strategies used by human immunodeficiency virus that allow persistent viral replication. Nature Med. 5, 723–725 (1999). (10.1038/10439) / Nature Med. by RC Desrosiers (1999)
  7. Brown, P. Integration. in Retroviruses (eds. Coffin, J.M., Hughes, S.H. & Varmus, H.E.) 161–203 (Cold Spring harbor Laboratory Press, Cold Spring Harbor, New York, 1997).
  8. Engleman, A., Englund, G., Orenstein, J.M., Martin, M.A. & Craigie, R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69, 2729–2736 (1995). (10.1128/JVI.69.5.2729-2736.1995) / J. Virol. by A Engleman (1995)
  9. Masuda, T., Planelles, V., Krogstad, P. & Chen, I.S.Y. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: Unusual phenotype of mutants in the zinc finger-like domain. J. Virol. 69, 6687–6696 (1995). (10.1128/JVI.69.11.6687-6696.1995) / J. Virol. by T Masuda (1995)
  10. Wu, X. et al. Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J. Virol. 73, 2126–2135 (1999). (10.1128/JVI.73.3.2126-2135.1999) / J. Virol. by X Wu (1999)
  11. Leavitt, A.D., Robles, G., Alesandro, N. & Varmus, H.E. Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrase viral DNA efficiently during infection. J. Virol. 70, 721–728 (1996). (10.1128/JVI.70.2.721-728.1996) / J. Virol. by AD Leavitt (1996)
  12. Nakamura, T. et al. Lack of infectivity of HIV-1 integrase zinc finger-like domain mutant with morphologically normal maturation. Biochem. Biophys. Res. Commun. 239, 715–722 (1997). (10.1006/bbrc.1997.7541) / Biochem. Biophys. Res. Commun. by T Nakamura (1997)
  13. Kalpana, G.V., Marmon, S., Wang, W., Crabtree, G.R. & Goff, S.P. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 266, 2002–2006 (1994). (10.1126/science.7801128) / Science by GV Kalpana (1994)
  14. Morozov, A., Yung, E. & Kalpana, G. Structure-function analysis of integrase interactor 1L1 reveals differential properties of two repeat motifs present in the highly conserved region. Proc. Natl. Acad. Sci. USA 95, 1120–1125 (1998). (10.1073/pnas.95.3.1120) / Proc. Natl. Acad. Sci. USA by A Morozov (1998)
  15. Versteege, I. et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394, 203–206 (1998). (10.1038/28212) / Nature by I Versteege (1998)
  16. Biegel, J.A. et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 59, 74–79 (1999). / Cancer Res. by JA Biegel (1999)
  17. Wang, W. et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J. 15, 5370–82 (1996). (10.1002/j.1460-2075.1996.tb00921.x) / EMBO J. by W Wang (1996)
  18. Kingston, R.E. & Narlikar, G.J. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev. 13, 2339–52 (1999). (10.1101/gad.13.18.2339) / Genes Dev. by RE Kingston (1999)
  19. Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263–267 (1996). (10.1126/science.272.5259.263) / Science by L Naldini (1996)
  20. Leung, D.W., Chen, E. & Goeddel, D.V. A method for random mutagenesis of a defined DNA segment using a modified polymerase chain reaction. Techique 1, 11–15 (1989). / Techique by DW Leung (1989)
  21. Wu, X. et al. Functional RT and integrase incorporated into HIV-1 particles independently of the Gag/Pol precursor protein. EMBO J. 16, 5113–22 (1997). (10.1093/emboj/16.16.5113) / EMBO J. by X Wu (1997)
  22. Adachi, A. et al. Generation and characterization of human immunodeficiency virus type 1 mutants. Arch. Virol. 117, 45–58 (1991). (10.1007/BF01310491) / Arch. Virol. by A Adachi (1991)
  23. Ansari-Lari, M.A., Donehower, L.A. & Gibbs, R.A. Analysis of human immunodeficiency virus type 1 integrase mutants. Virol. 211, 332–335 (1995). (10.1006/viro.1995.1412) / Virol. by MA Ansari-Lari (1995)
  24. Cannon, P.M., Wilson, M., Byles, E., Kingsman, S.M. & Kingsman, A.J. Human immunodeficiency virus type 1 integrase: Effect on viral replication of mutations at highly conserved residues. J. Virol. 68, 4768–4775 (1994). (10.1128/JVI.68.8.4768-4775.1994) / J. Virol. by PM Cannon (1994)
  25. Gallay, P., Swingler, S., Song, J., Bushman, F. & Trono, D. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83, 569–576 (1995). (10.1016/0092-8674(95)90097-7) / Cell by P Gallay (1995)
  26. Stevenson, M., Stanwick, T.L., Dempsey, M.P. & Lamonica, C.A. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9, 1551–1560 (1990). (10.1002/j.1460-2075.1990.tb08274.x) / EMBO J. by M Stevenson (1990)
  27. Wiskerchen, M. & Muesing, M.A. Human immunodeficiency virus type 1 integrase: Effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates and sustain viral propagation in primary cells. J. Virol. 69, 376–386 (1995). (10.1128/JVI.69.1.376-386.1995) / J. Virol. by M Wiskerchen (1995)
  28. Fletcher, T.M., 3rd et al. Complementation of integrase function in HIV-1 virions. EMBO J. 16, 5123–38 (1997). (10.1093/emboj/16.16.5123) / EMBO J. by TM Fletcher 3rd (1997)
  29. Muchardt, C., Sardet, C., Bourachot, B., Onufryk, C. & Yaniv, M. A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm. Nucleic Acids Res. 23, 1127–32 (1995). (10.1093/nar/23.7.1127) / Nucleic Acids Res. by C Muchardt (1995)
  30. Ott, D.E. et al. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J. Virol. 70, 7734–7743 (1996). (10.1128/JVI.70.11.7734-7743.1996) / J. Virol. by DE Ott (1996)
  31. Bukovsky, A. & Gottlinger, H. Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease. J. Virol. 70, 6820–6825 (1996). (10.1128/JVI.70.10.6820-6825.1996) / J. Virol. by A Bukovsky (1996)
  32. Swanstrom, R. & Wills, J.W. Synthesis, assembly and processing of viral proteins. in Retroviruses (eds. Coffin, J.M., Hughes, S.H. & Varmus, H.E.) 263–334 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1997).
  33. Cheng, S.-W. G. et al. c-MYC interacts with INII/hSNF5 and requires the SWI/SNF complex for transactivation function. Nature Gen. 22, 102–105 (1999). (10.1038/8811) / Nature Gen. by S-WG Cheng (1999)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:32 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 7:27 p.m.)
Indexed 5 days, 7 hours ago (Aug. 24, 2025, 6:56 p.m.)
Issued 24 years ago (Aug. 1, 2001)
Published 24 years ago (Aug. 1, 2001)
Published Online 24 years ago (Aug. 1, 2001)
Published Print 24 years ago (Aug. 1, 2001)
Funders 0

None

@article{Yung_2001, title={Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1}, volume={7}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/90959}, DOI={10.1038/90959}, number={8}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Yung, Eric and Sorin, Masha and Pal, Achintya and Craig, Errol and Morozov, Alexei and Delattre, Olivier and Kappes, John and Ott, David and Kalpana, Ganjam V.}, year={2001}, month=aug, pages={920–926} }